Categories: Health

Declaration of shares and voting rights of Valneva SE March 2026

VALNEVA

Declaration of shares and voting rights
March 31, 2026
__________________________________________________________________________________________

Company name: VALNEVA
Registered office: Îlot Saint-Joseph Bureaux Convergence – Bât. A, 12 ter Quai Perrache – 69002 Lyon
Regulated market of Euronext Paris – Compartment B

Declaration date: April 3, 2026

Number of shares
composing the share capital of Valneva
Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights**
 

173,877,420

ordinary shares with a par value of €0.15 each

188,465,862 Transfer into bearer form of 521,353 shares with double voting rights

Double voting rights granted on 119,111 ordinary shares

Between March 3 & March 23, 2026

Between March 5 & March 22, 2026

188,341,540

___________________________

* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.
** Net (or exercisable at a General Meeting) voting rights.

GlobeNews Wire

Recent Posts

B612 Foundation Announces 2026 Winner of the Schweickart Prize

University of Edinburgh Researchers Brian P. Murphy and Richard E. Cannon Recognized for Proposal to…

3 minutes ago

Chandigarh University Uttar Pradesh Signs MoU with Film Society of India to Establish ‘Film Gurukul Studio’ to Nurture Future-ready Filmmakers

Chandigarh University UP Collaborates with Film Society of India to Cultivate Future-ready Media Professionals through…

7 hours ago

Pioneering screening test offers potential to find more aggressive prostate cancers

STOCKHOLM, June 22, 2026 (GLOBE NEWSWIRE) -- A3P Biomedical, a diagnostics company specializing in prostate…

10 hours ago

20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month

Inaugural Session to be Held Wednesday, July 1, 2026, at 12:00 p.m. ET Recurring Forum…

10 hours ago

MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD Approval

ROCKVILLE, MD, June 22, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical…

10 hours ago

Bybit EU Strengthens European Positioning Ahead of MiCAR Transition

VIENNA, June 22, 2026 /PRNewswire/ -- As the various national MiCAR transition periods approach their…

11 hours ago